Ipilimumab vs Spironolactone
Ipilimumab vs Spironolactone: Overview
This comparison examines the pharmacological differences between Ipilimumab and Spironolactone.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Spironolactone: Mineralocorticoid receptor antagonist.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Spironolactone β 1.4 hours.
Chemical Properties
Molecular Formula: Spironolactone β C24H32O4S.
Molecular Weight: Spironolactone β 416.5740 g/mol.
Type: Ipilimumab β Antibody; Spironolactone β Small molecule.